December 2, 2022
Masako Futagami, Executive Officer, Vice President, Respiratory & Immunology Business Unit, AstraZeneca K.K. Over the past years, AstraZeneca has enjoyed a spate of respiratory drug launches in Japan, with Tezspire (tezepelumab) becoming the latest addition to the franchise in November...read more